July 2016 DT0716_Cvjump-1.jpg
Treating the AK fieldInnovative modifications of conventional treatments for actinic keratosis (AK) can help patients live with this chronic disease in more comfort and greater safety, and with potentially improved outcomes.
A simple complication, a massive lawsuitLegal arguments can be based on foreseeable complications, even when physicians are safety conscious.
Progress for Women in Medicine Slow, but SignificantLeadership roles for women in dermatology are increasing slowly but surely.
Integrative and alternative treatments for seborrheic dermatitisEssential oils, aloe vera, supplements, diet, and other solutions may be of use for patients who request alternative or integrative treatments for seborrheic dermatitis.
The oral pipeline for psoriasisOral options in the pipeline for psoriasis show promise.
Revance injectable outperforms BotoxAccording to early research, not-yet-approved RT002 (DaxibotulinumtoxinA for Injection, Revance Therapeutics) lasts longer, might be safer and offers more dramatic wrinkle reduction than today’s most popular neurotoxin Botox (Allergan).
Financial Self-Defense for DermatologistsEducation is crucial for protecting yourself from possible misconduct from financial advisors. Recognizing these red flags can help you choose wisely and avoid mistakes.
Scientists gain new insight into UV-exposure geneticsXeroderma pigmentosum is a rare disease that leads to early skin cancer. New insights may lead to better prevention and survival for patients, as well as point to ways that UV-resistant gene functions could be used for skin cancer prevention and treatment.
Professionalism in social media is a balancing actTo establish and maintain a professional medical image in social media, pay careful attention to the content of posts. Be aware that social media content is admissible as evidence in courts of law.
Meaningful use losing its meaning?Regulations surrounding electronic health records are evolving. The medical community waits hopefully for a system that focuses more on outcomes and less on the use of technology itself.